Annual CFO
-$52.04 M
+$18.95 M+26.69%
December 31, 2023
Summary
- As of March 6, 2025, PAVM annual cash flow from operations is -$52.04 million, with the most recent change of +$18.95 million (+26.69%) on December 31, 2023.
- During the last 3 years, PAVM annual CFO has fallen by -$30.12 million (-137.46%).
- PAVM annual CFO is now -4064.21% below its all-time high of -$1.25 million, reached on December 31, 2015.
Performance
PAVM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.88 M
+$2.77 M+23.79%
September 30, 2024
Summary
- As of March 6, 2025, PAVM quarterly cash flow from operations is -$8.88 million, with the most recent change of +$2.77 million (+23.79%) on September 30, 2024.
- Over the past year, PAVM quarterly CFO has stayed the same.
- PAVM quarterly CFO is now -15321.88% below its all-time high of -$57.60 thousand, reached on March 31, 2015.
Performance
PAVM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$45.52 M
+$2.21 M+4.62%
September 30, 2024
Summary
- As of March 6, 2025, PAVM TTM cash flow from operations is -$45.52 million, with the most recent change of +$2.21 million (+4.62%) on September 30, 2024.
- Over the past year, PAVM TTM CFO has stayed the same.
- PAVM TTM CFO is now -78931.25% below its all-time high of -$57.60 thousand, reached on March 31, 2015.
Performance
PAVM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
PAVM Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +26.7% | 0.0% | 0.0% |
3 y3 years | -137.5% | +60.6% | +23.6% |
5 y5 years | -492.1% | +60.6% | +23.6% |
PAVM Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -28.2% | +26.7% | at high | +60.6% | -12.2% | +39.4% |
5 y | 5-year | -289.6% | +26.7% | -134.3% | +60.6% | -242.8% | +39.4% |
alltime | all time | -4064.2% | +26.7% | <-9999.0% | +60.6% | <-9999.0% | +39.4% |
PAVmed Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$8.88 M(-23.8%) | -$45.52 M(-4.6%) |
Jun 2024 | - | -$11.66 M(-11.1%) | -$47.73 M(-2.2%) |
Mar 2024 | - | -$13.11 M(+10.4%) | -$48.78 M(-6.3%) |
Dec 2023 | -$52.04 M(-26.7%) | -$11.87 M(+7.1%) | -$52.04 M(-8.7%) |
Sep 2023 | - | -$11.09 M(-12.8%) | -$56.98 M(-12.6%) |
Jun 2023 | - | -$12.71 M(-22.3%) | -$65.24 M(-13.1%) |
Mar 2023 | - | -$16.36 M(-2.7%) | -$75.08 M(+5.8%) |
Dec 2022 | -$70.98 M(+74.9%) | -$16.82 M(-13.0%) | -$70.98 M(+0.1%) |
Sep 2022 | - | -$19.34 M(-14.3%) | -$70.94 M(+19.0%) |
Jun 2022 | - | -$22.56 M(+84.0%) | -$59.62 M(+36.5%) |
Mar 2022 | - | -$12.26 M(-26.9%) | -$43.69 M(+7.6%) |
Dec 2021 | -$40.59 M(+85.2%) | -$16.78 M(+109.2%) | -$40.59 M(+32.9%) |
Sep 2021 | - | -$8.02 M(+21.0%) | -$30.54 M(+7.7%) |
Jun 2021 | - | -$6.63 M(-27.7%) | -$28.36 M(+3.9%) |
Mar 2021 | - | -$9.17 M(+36.3%) | -$27.29 M(+24.5%) |
Dec 2020 | -$21.91 M(+64.1%) | -$6.73 M(+15.2%) | -$21.91 M(+13.7%) |
Sep 2020 | - | -$5.84 M(+5.1%) | -$19.28 M(+18.2%) |
Jun 2020 | - | -$5.55 M(+46.5%) | -$16.31 M(+22.9%) |
Mar 2020 | - | -$3.79 M(-7.3%) | -$13.28 M(-0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | -$13.36 M(+52.0%) | -$4.09 M(+42.1%) | -$13.36 M(+8.7%) |
Sep 2019 | - | -$2.88 M(+14.3%) | -$12.29 M(+9.0%) |
Jun 2019 | - | -$2.52 M(-34.9%) | -$11.27 M(+7.8%) |
Mar 2019 | - | -$3.87 M(+28.2%) | -$10.46 M(+19.0%) |
Dec 2018 | -$8.79 M(+33.0%) | -$3.02 M(+61.8%) | -$8.79 M(+19.5%) |
Sep 2018 | - | -$1.87 M(+9.7%) | -$7.36 M(-6.4%) |
Jun 2018 | - | -$1.70 M(-22.6%) | -$7.86 M(+12.6%) |
Mar 2018 | - | -$2.20 M(+38.6%) | -$6.98 M(+5.7%) |
Dec 2017 | -$6.61 M(+48.3%) | -$1.59 M(-33.1%) | -$6.61 M(+6.2%) |
Sep 2017 | - | -$2.37 M(+188.1%) | -$6.22 M(+22.6%) |
Jun 2017 | - | -$823.60 K(-54.9%) | -$5.08 M(-11.9%) |
Mar 2017 | - | -$1.83 M(+51.7%) | -$5.76 M(+29.3%) |
Dec 2016 | -$4.45 M(+256.5%) | -$1.20 M(-1.9%) | -$4.45 M(+14.2%) |
Sep 2016 | - | -$1.23 M(-18.6%) | -$3.90 M(+30.4%) |
Jun 2016 | - | -$1.51 M(+190.4%) | -$2.99 M(+74.8%) |
Mar 2016 | - | -$518.70 K(-20.0%) | -$1.71 M(+36.9%) |
Dec 2015 | -$1.25 M | -$648.00 K(+103.9%) | -$1.25 M(+107.7%) |
Sep 2015 | - | -$317.80 K(+40.5%) | -$601.60 K(+112.0%) |
Jun 2015 | - | -$226.20 K(+292.7%) | -$283.80 K(+392.7%) |
Mar 2015 | - | -$57.60 K | -$57.60 K |
FAQ
- What is PAVmed annual cash flow from operations?
- What is the all time high annual CFO for PAVmed?
- What is PAVmed annual CFO year-on-year change?
- What is PAVmed quarterly cash flow from operations?
- What is the all time high quarterly CFO for PAVmed?
- What is PAVmed quarterly CFO year-on-year change?
- What is PAVmed TTM cash flow from operations?
- What is the all time high TTM CFO for PAVmed?
- What is PAVmed TTM CFO year-on-year change?
What is PAVmed annual cash flow from operations?
The current annual CFO of PAVM is -$52.04 M
What is the all time high annual CFO for PAVmed?
PAVmed all-time high annual cash flow from operations is -$1.25 M
What is PAVmed annual CFO year-on-year change?
Over the past year, PAVM annual cash flow from operations has changed by +$18.95 M (+26.69%)
What is PAVmed quarterly cash flow from operations?
The current quarterly CFO of PAVM is -$8.88 M
What is the all time high quarterly CFO for PAVmed?
PAVmed all-time high quarterly cash flow from operations is -$57.60 K
What is PAVmed quarterly CFO year-on-year change?
Over the past year, PAVM quarterly cash flow from operations has changed by $0.00 (0.00%)
What is PAVmed TTM cash flow from operations?
The current TTM CFO of PAVM is -$45.52 M
What is the all time high TTM CFO for PAVmed?
PAVmed all-time high TTM cash flow from operations is -$57.60 K
What is PAVmed TTM CFO year-on-year change?
Over the past year, PAVM TTM cash flow from operations has changed by $0.00 (0.00%)